Tandem Diabetes Care, Inc. priced an upsized private placement of $265.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032, increased from the previously announced $200.0 million. The company also granted initial purchasers an option to buy up to an additional $35.0 million of the notes within 13 days of issuance, with the offering expected to close on February 27, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tandem Diabetes Care Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260224110820) on February 25, 2026, and is solely responsible for the information contained therein.
Comments